Your browser doesn't support javascript.
loading
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients.
Lavanderos, María A; Cayún, Juan P; Roco, Ángela; Sandoval, Christopher; Cerpa, Leslie; Rubilar, Juan C; Cerro, Roberto; Molina-Mellico, Sebastián; Celedón, Cesar; Cerda, Berta; García-Martín, Elena; Agúndez, José A G; Acevedo, Cristián; Peña, Karina; Cáceres, Dante D; Varela, Nelson M; Quiñones, Luis A.
Afiliação
  • Lavanderos MA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Cayún JP; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Roco Á; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Sandoval C; Servicio Metropolitano de Salud Occidente, Santiago, Chile.
  • Cerpa L; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Rubilar JC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Cerro R; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Molina-Mellico S; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Celedón C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Cerda B; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • García-Martín E; Instituto Nacional del Cáncer, Santiago, Chile.
  • Agúndez JAG; Institute of Molecular Pathology Biomarkers, ARADyAL, University of Extremadura, Cáceres, Spain.
  • Acevedo C; Institute of Molecular Pathology Biomarkers, ARADyAL, University of Extremadura, Cáceres, Spain.
  • Peña K; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Cáceres DD; Clinical Hospital University of Chile, Santiago, Chile.
  • Varela NM; Department of Oncology, Hospital San Juan de Dios, Santiago, Chile.
  • Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
Front Pharmacol ; 10: 206, 2019.
Article em En | MEDLINE | ID: mdl-30914949
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article